Millennium Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Sell |
492,614
-451,470
| -48% | -$187K | ﹤0.01% | 3694 |
|
|
2025
Q1 | $588K | Sell |
944,084
-1,185,026
| -56% | -$738K | ﹤0.01% | 3224 |
|
|
2024
Q4 | $3.56M | Buy |
2,129,110
+126,736
| +6% | +$212K | ﹤0.01% | 2207 |
|
|
2024
Q3 | $3.64M | Buy |
2,002,374
+677,178
| +51% | +$1.23M | ﹤0.01% | 2181 |
|
|
2024
Q2 | $7.99M | Buy |
1,325,196
+1,265,006
| +2,102% | +$7.63M | ﹤0.01% | 1621 |
|
|
2024
Q1 | $671K | Buy |
+60,190
| New | +$671K | ﹤0.01% | 3166 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4053 |
|
|
2023
Q3 | – | Sell |
-123,933
| Closed | -$931K | – | 4137 |
|
|
2023
Q2 | $931K | Buy |
123,933
+71,027
| +134% | +$533K | ﹤0.01% | 2957 |
|
|
2023
Q1 | $239K | Sell |
52,906
-34,540
| -39% | -$156K | ﹤0.01% | 3782 |
|
|
2022
Q4 | $986K | Sell |
87,446
-144,716
| -62% | -$1.63M | ﹤0.01% | 3181 |
|
|
2022
Q3 | $2.22M | Sell |
232,162
-197,118
| -46% | -$1.89M | ﹤0.01% | 2785 |
|
|
2022
Q2 | $3.47M | Buy |
429,280
+395,248
| +1,161% | +$3.2M | ﹤0.01% | 2452 |
|
|
2022
Q1 | $575K | Sell |
34,032
-107,686
| -76% | -$1.82M | ﹤0.01% | 3989 |
|
|
2021
Q4 | $3.05M | Buy |
+141,718
| New | +$3.05M | ﹤0.01% | 2625 |
|
|
2021
Q3 | – | Sell |
-12,230
| Closed | -$669K | – | 5076 |
|
|
2021
Q2 | $669K | Buy |
+12,230
| New | +$669K | ﹤0.01% | 3986 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4440 |
|